Skip to main content
Clinical Trials/NCT06255353
NCT06255353
Completed
Not Applicable

Effect of Different Feeding Modes in Intracerebral Hemorrhage: Improving Clinical Outcomes and Safety

Zeng Changhao2 sites in 1 country118 target enrollmentFebruary 28, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intracerebral Hemorrhage
Sponsor
Zeng Changhao
Enrollment
118
Locations
2
Primary Endpoint
Number of cases of successful extubation
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

This was a multicenter, prospective, randomized controlled clinical trail involved tracheostomized patients with Intracerebral Hemorrhage.The goal of this clinical trial is to compare the clinical effect of Intermittent Oro-esophageal Tube Feeding vs Nasogastric Tube Feeding in Tracheostomized Patients with Intracerebral Hemorrhage. The main questions it aims to answer are:

Compared to Nasogastric Tube Feeding, can the Intermittent Oro-esophageal Tube Feeding better improve the nutritional status, extubation of tracheostomy tube, pulmonary infection, neurological deficit of Patients with Intracerebral Hemorrhage Compared to Nasogastric Tube Feeding, is the Intermittent Oro-esophageal Tube Feeding safer.

Participants will be divided into two groups randomly, with different nutritional support respectively.

Detailed Description

Safe and efficient enteral nutrition support for tracheostomized patients with intracerebral hemorrhage continues to be a challenge. Nasogastric tube feeding has been the mainstay in China but has a significant risk of adverse events. Intermittent oro-esophageal tube feeding is an established enteral nutrition mode that can be used to replace Nasogastric tube feeding. This study reports the clinical effect of Intermittent oro-esophageal tube feeding vs Nasogastric tube feeding in tracheostomized patients with intracerebral hemorrhage receiving basic medical treatment and comprehensive rehabilitation therapy. However, in the field of intracerebral hemorrhage combined with tracheostomy, research on Intermittent oro-esophageal tube feeding is still relatively limited. Therefore, this study was carried out to explore the clinical effect of Intermittent oro-esophageal tube feeding vs. Nasogastric tube feeding in tracheostomized patients with intracerebral hemorrhage, mainly on nutritional status, extubation of tracheostomy tube, pulmonary infection, neurological deficit, and intervention-related adverse events.

Registry
clinicaltrials.gov
Start Date
February 28, 2024
End Date
November 20, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Zeng Changhao
Responsible Party
Sponsor Investigator
Principal Investigator

Zeng Changhao

PI

People's Hospital of Zhengzhou University

Eligibility Criteria

Inclusion Criteria

  • meeting the diagnostic criteria for Intracerebral Hemorrhage.
  • with placement of a tracheotomy tube.
  • requiring enteral nutrition support.
  • age over 18 years.
  • able to cooperate with treatment and questionnaire investigation.

Exclusion Criteria

  • combined with tumors in the head, neck, esophagus, or gastrointestinal tract
  • an abnormal structure observed in the oral, pharyngeal, nasal regions or esophagus
  • with unstable vital signs or severe dysfunction of organs including heart, liver, lungs, or kidneys
  • with severe hemorrhagic disease or bleeding tendency;
  • with contraindications for enteral nutrition
  • with dysphagia caused by non-stroke-related reasons in the past

Outcomes

Primary Outcomes

Number of cases of successful extubation

Time Frame: day 30

The Number of cases of successful extubation for both groups was recorded and compared. The parameters or criteria for extubation were: 1) stable clinical condition and a respiratory rate of 12-22 breaths per minute. 2) strong coughing ability and minimal airway secretions. 3) after completing a trial of tracheostomy tube capping, patients showed no fever, dyspnea, or asthma within 72 hours. Additionally, their blood oxygen saturation remained above 95% and normal oxygen partial pressure was observed

Secondary Outcomes

  • Body mass index(day 1 and day 30)
  • Serum albumin(day 1 and day 30)
  • Hemoglobin(day 1 and day 30)
  • Clinical Pulmonary Infection Score(day 1 and day 30)
  • National Institutes of Health Stroke Scale(day 1 and day 30)

Study Sites (2)

Loading locations...

Similar Trials